Video
Thom Cohn, chief strategy officer, Asembia, discusses recent developments in specialty pharmacy models.
Thom Cohn, chief strategy officer, Asembia, discusses recent developments in specialty pharmacy models.
Thom Cohn: Well, the specialty model is evolving, and there's been a lot of recent developments in specialty pharmacy, whether it's new therapies, digital therapies, digital solutions for patients, or just new ways to interact with patients.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a